Overview: CD4 Percentage TestIntroduction: The CD4 Percentage Test measures the percentage of CD4 T-cells to assess immune system health, especially in HIV or immunodeficiency, helping monitor disease progression or treatment. Affecting 1 in 1,000 HIV patients annually, immune decline poses diagnostic challenges. Following 2023 International AIDS Society (IAS) guidelines, it uses flow cytometry for high accuracy, supporting hematology screening. This test is vital for diagnosis, monitoring, and improving outcomes in infectious disease management.
Other Names: CD4% Test, T-Helper Cell Percentage Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: Immune marker testing began in the 1980s with research by Gottlieb, who linked CD4 to HIV. Flow cytometry advancements in the 1990s by BD Biosciences improved detection, surpassing earlier manual counts.
Purpose: Measures CD4 percentage to assess HIV or immunodeficiency, guides antiretroviral therapy, and evaluates patients with infections, aiming to prevent AIDS.
Test Parameters: CD4 T-cell percentage
Pretest Condition: No special preparation required. Collect whole blood. Report history of HIV or infections.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not recommended
Medical History: Document recurrent infections or HIV history. Include current medications or treatment history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., AIDS), and sample collection risks.
Procedural Considerations: Uses flow cytometry to measure CD4%, requiring labs with flow cytometers. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter counts, requiring correlation.
Clinical Significance: Low CD4% indicates immune decline, guiding therapy. Early intervention might prevent AIDS, while untreated cases lead to death. Normal levels may suggest health.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: CD4 count, viral load, or immune panel to confirm diagnosis.
Test Limitations: Specific to CD4%; correlation with absolute count needed. Variability in counts may occur.
References: IAS Guidelines, 2023; New England Journal of Medicine, Gottlieb MS, 2022.
